These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6636179)

  • 21. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic influences on tolerance development with chronic oxotremorine infusion.
    Marks MJ; Romm E; Collins AC
    Pharmacol Biochem Behav; 1987 Aug; 27(4):723-32. PubMed ID: 3659096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muscarinic cholinergic receptor-mediated control of cyclic AMP metabolism. Agonist-induced changes in nucleotide synthesis and degradation.
    Meeker RB; Harden TK
    Mol Pharmacol; 1983 Mar; 23(2):384-92. PubMed ID: 6300648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR; Wolfe BB
    Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.
    Martin MW; Smith MM; Harden TK
    J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of the anticholinesterase activity of a series of organophosphates with their ability to compete with agonist binding to muscarinic receptors.
    Ward TR; Ferris DJ; Tilson HA; Mundy WR
    Toxicol Appl Pharmacol; 1993 Oct; 122(2):300-7. PubMed ID: 8212012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of a radiolabeled agonist with cardiac muscarinic cholinergic receptors.
    Harden TK; Meeker RB; Martin MW
    J Pharmacol Exp Ther; 1983 Dec; 227(3):570-7. PubMed ID: 6317839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sialic acid is selectively involved in the interaction of agonists with M2 muscarinic acetylcholine receptors.
    Gies JP; Landry Y
    Biochem Biophys Res Commun; 1988 Jan; 150(2):673-80. PubMed ID: 3342042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An alkylating derivative of oxotremorine interacts irreversibly with the muscarinic receptor.
    Ehlert FJ; Jenden DJ; Ringdahl B
    Life Sci; 1984 Mar; 34(10):985-91. PubMed ID: 6700365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscarinic receptor alterations following neostigmine treatment.
    Costa LG; Schwab BW; Murphy SD
    Eur J Pharmacol; 1982 May; 80(2-3):275-8. PubMed ID: 7106184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of organophosphate exposure on muscarinic acetylcholine receptor subtype mRNA levels in the adult rat.
    Yagle K; Costa LG
    Neurotoxicology; 1996; 17(2):523-30. PubMed ID: 8856746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
    el-Fakahany EE; Ramkumar V; Lai WS
    J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo regulation of muscarinic cholinergic receptors in embryonic chick brain.
    Meyer MR; Gainer MW; Nathanson NM
    Mol Pharmacol; 1982 Mar; 21(2):280-6. PubMed ID: 7099136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative in vivo effects of parathion on striatal acetylcholine accumulation in adult and aged rats.
    Karanth S; Liu J; Ray A; Pope C
    Toxicology; 2007 Oct; 239(3):167-79. PubMed ID: 17707571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholinergic drug effects and brain muscarinic receptor binding in aged rats.
    Pedigo NW; Minor LD; Krumrei TN
    Neurobiol Aging; 1984; 5(3):227-33. PubMed ID: 6514108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists.
    Xu J; Chuang DM
    J Pharmacol Exp Ther; 1987 Jul; 242(1):238-44. PubMed ID: 3039110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerance to anticholinesterase compounds in mammals.
    Costa LG; Schwab BW; Murphy SD
    Toxicology; 1982; 25(2-3):79-97. PubMed ID: 6760465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
    Dunlap J; Brown JH
    Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholinergic adaptations to chronic oxotremorine infusion.
    Marks MJ; Artman LD; Patinkin DM; Collins AC
    J Pharmacol Exp Ther; 1981 Aug; 218(2):337-43. PubMed ID: 7252834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Affinity ligands and related agents for brain muscarinic and nicotinic cholinergic receptors.
    Abood LG; Saraswati M; Lerner-Marmarosh N; Hashmi M
    Biochem Pharmacol; 1993 May; 45(10):2143-8. PubMed ID: 8512596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.